Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
148.68
-0.23 (-0.15%)
Official Closing Price
Updated: 7:00 PM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,147,271
Open
149.49
Bid (Size)
145.08 (100)
Ask (Size)
150.00 (1,700)
Prev. Close
148.91
Today's Range
148.13 - 149.98
52wk Range
97.72 - 152.48
Shares Outstanding
N/A
Dividend Yield
2.69%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Biological Singularity: How Nobel-Winning AlphaFold 3 is Rewriting the Blueprint of Life
January 28, 2026
In the annals of scientific history, few moments represent a clearer "before and after" than the arrival of AlphaFold 3. Developed by Google DeepMind and its dedicated drug-discovery arm, Isomorphic...
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Lilly Bolsters Immunology Arsenal with $1.2 Billion Acquisition of Ventyx Biosciences
January 28, 2026
In a strategic move to solidify its dominance in the burgeoning field of oral anti-inflammatories, Eli Lilly and Company (NYSE:LLY) announced on January 7, 2026, a definitive agreement to acquire...
Via
MarketMinute
Performance
YTD
+7.3%
+7.3%
1 Month
+7.8%
+7.8%
3 Month
+20.1%
+20.1%
6 Month
+29.0%
+29.0%
1 Year
+41.9%
+41.9%
More News
Read More
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals
↗
January 23, 2026
Via
Chartmill
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case
↗
January 20, 2026
Via
Chartmill
The Master Architect of Molecules: How Google DeepMind’s AlphaProteo is Rewriting the Blueprint for Cancer Therapy
January 27, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Why I Am Buying the Schwab International Equity ETF (SCHF) and Never Looking Back
↗
January 27, 2026
Via
The Motley Fool
Topics
ETFs
Economy
The Silicon Laureates: How the 2024 Nobel Prizes Rewrote the Rules of Scientific Discovery
January 26, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026?
January 26, 2026
Via
Barchart.com
Topics
World Trade
International ETFs: SPDW and SCHF Both Offer Low Cost International Exposure
↗
January 24, 2026
Via
The Motley Fool
Topics
ETFs
VWO vs. SPDW: How Does a Emerging Markets ETF Fair Against a Developed World Fund?
↗
January 24, 2026
Via
The Motley Fool
Topics
ETFs
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Novartis Positions US Strategy As Defense Against Rising Trade Levies
↗
January 23, 2026
Via
Benzinga
Topics
Government
World Trade
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Initial Public Offering
The Software Stock That Could Be 2026's Biggest Surprise
↗
January 22, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
January 20, 2026
Via
MarketMinute
Topics
Intellectual Property
Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine
January 19, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
International Exposure: SPDW's Lower Costs vs. URTH's U.S. Giants
↗
January 17, 2026
Via
The Motley Fool
Topics
ETFs
The Atomic Revolution: How AlphaFold 3 is Redefining the Future of Medicine
January 16, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment
↗
January 16, 2026
Via
Stocktwits
The Atomic Revolution: How AlphaFold 3’s Open-Source Pivot Has Redefined Global Drug Discovery in 2026
January 15, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Derivatives
Economy
The Silicon Laureates: How the 2024 Nobel Prizes Cemented AI as the New Language of Science
January 15, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
IEFA vs. SPDW: Broad International Exposure With Different Portfolio Designs
↗
January 14, 2026
Via
The Motley Fool
Topics
ETFs
The Silicon Laureates: How 2024’s ‘Nobel Prize Moment’ Rewrote the Laws of Scientific Discovery
January 14, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Electric Vehicles
The Digital Microscope: How AlphaFold 3 is Decoding the Molecular Language of Life
January 14, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Bonds
SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout
↗
January 14, 2026
Via
Stocktwits
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 148.68
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 01/30/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.